Braze, Inc. <BRZE.O>: Oppenheimer Raises Target Price to $36 From $30
BRZE•Related News
China's drug regulator accepts Novo Nordisk's application for oral Wegovy
NVO•
Lucky Strike Entertainment slips after Q4 revenue miss
LUCK•
Wynn Macau FY26 H1 profit attributable to owners more than doubled to HK$ 1.55 billion; revenue rises 14.4% to HK$ 15.59 billion
WYNN•
Okta, Inc. <OKTA.O>: Oppenheimer Raises Target Price to $190 From $170
OKTA•
BranchOut Food prices 820,588-share follow-on at USD 3.4, raising USD 2.79 million
BOF•